Hansard Adam

Insider profile

Performance

Overall performance
3.0

Performance over holding periods
3.0
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Hansard Adam's trades of Applied Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
269.27
Quantity 50,884
Value US$3,004,972
Transaction date
Proposed sale
Price
215.46
Quantity 34,180
Value US$1,195,693
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-05-17 2024-05-17 PrS Proposed sale
50,884
269.27
US$3,004,972
50,884 269.27 US$3,004,972
2024-05-16 2024-05-16 PrS Proposed sale
34,180
215.46
US$1,195,693
34,180 215.46 US$1,195,693
2024-03-18 2024-03-14 S Sale
29,723 -42.2%
274.15
US$262,063
29,723 -42.2% 274.15 US$262,063
2023-12-01 2023-11-30 S Sale
965 -0.3%
1.97
US$1,901
965 -0.3% 1.97 US$1,901
2023-09-29 2023-09-27 S Sale
9,720 -2.5%
2.70
US$26,244
9,720 -2.5% 2.70 US$26,244
2023-01-13 2023-01-11 S Sale
4,495 -4.6%
0.91
US$4,090
4,495 -4.6% 0.91 US$4,090
2021-05-28 2021-05-26 S Sale
2,894 -7.9%
18.35
US$53,105
2,894 -7.9% 18.35 US$53,105